Elysium

📍 Rome, Italy🗓 Founded 2019👥 73 employees💰 Last funded Jan 2019
IT Services and IT Consulting🌐 elysium.tech
Website LinkedIn
Elysium aims to become a leading healthcare data analytics provider in the European market by 2026. That's why we developed Medory, the first free platform that allows people to easily share their medical history with doctors, anywhere in the world. Thanks to Medory we will have access to a huge amount of health data, which once anonymized and clustered will allow us to create datasets of incredible quality for medical-scientific and pharmaceutical research, with the aim of bringing out new knowledge that would otherwise be inaccessible. Starting from the development and commercialization of Medory, Elysium, through the collection, classification and rationalization of health information, aims to transform the health system, facilitating the interaction between the different players and promoting the circulation of information. Through the integration of the different products and the different features designed, Elysium will create a data-driven and patient-centered healthcare system. Join the healthcare system revolution, join Elysium.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Shareholders· 2
Valerio Marone
Valerio Marone
Co-Founder at Own Your Business
Co-Founder & Shareholder
early stage
Jan 2019
?
Junior Business Developer & Shareholder
early stage
2018
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in Elysium?
Elysium has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Elysium last raise funding?
The most recent investment in Elysium recorded on gritt.io was in January 2019.
When was Elysium founded?
Elysium was founded in 2019.
What industry is Elysium in?
Elysium operates in IT Services and IT Consulting. Find similar IT Services and IT Consulting investors on gritt.io.
Where is Elysium based?
Elysium is headquartered in Rome, Italy.